GENOCEA BIOSCIENCES, INC. | Business Contracts

Collaboration and Option Agreement between the Company and Janssen Biotech, Inc., dated December 28, 2021 (Filed With SEC on March 18, 2022)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 18, 2022)

Form of Performance-Based Restricted Stock Unit Award Agreement under the Genocea Biosciences, Inc. 2014 Equity Incentive Plan (Filed With SEC on April 29, 2021)

Loan and Security Agreement between the Company and Silicon Valley Bank, dated February 18, 2021 (Filed With SEC on February 22, 2021)

Sublease between the Company and Zymergen Inc., dated November 30, 2020 (Filed With SEC on February 22, 2021)

Amended and Restated License Agreement between Genocea Biosciences, Inc. and President and Fellows of Harvard College, dated November 19, 2012 (Filed With SEC on February 13, 2020)

Warrant Agreement between the Company and Silicon Valley Bank, dated February 18, 2021 (Filed With SEC on February 22, 2021)

Form of Warrant (Filed With SEC on July 22, 2020)

Form of Purchase Agreement (Filed With SEC on July 22, 2020)

Form of Pre-Funded Warrant (Filed With SEC on July 22, 2020)

Genocea Biosciences, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on June 2, 2020)

Employment Letter Agreement between Girish Aakalu and Genocea Biosciences, Inc., dated December 6, 2018 (Filed With SEC on April 30, 2020)

Employment Letter Agreement between Thomas Davis and Genocea Biosciences, Inc., dated October 1, 2018 (Filed With SEC on April 30, 2020)

Form of Restricted Stock Unit Award Agreement under the Genocea Biosciences, Inc. 2014 Equity Incentive Plan (Filed With SEC on April 30, 2020)

Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 13, 2020)

Second Amendment to the Lease, dated May 1, 2019, between 100 Discovery Park DE, LLC, a Delaware limited liability company (as successor in interest to TBCI, LLC, as Trustee of... (Filed With SEC on February 13, 2020)

First Amendment to Amended and Restated Loan and Security Agreement between Genocea Biosciences, Inc. and Hercules Capital, Inc., dated April 24, 2018, as amended on November 14,... (Filed With SEC on November 19, 2019)

Registration Rights Agreement, dated as of October 23, 2019, by and between Genocea Biosciences, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 24, 2019)

Separation Agreement dated July 22, 2019 between Genocea Biosciences, Inc. and Pamela Carroll (Filed With SEC on July 25, 2019)

Form of Underwriting Agreement (Filed With SEC on June 18, 2019)

Subscription Agreement, dated as of February 11, 2019, among Genocea Biosciences, Inc. and the purchasers party thereto (Filed With SEC on April 30, 2019)

Amendment No. 2 to the Loan and Security Agreement between the Company and Hercules Technology Growth Capital, Inc., dated January 19, 2018 (Filed With SEC on February 28, 2019)

Form of Class B Warrant to Purchase Shares of Common Stock of Genocea Biosciences, Inc (Filed With SEC on February 28, 2019)

Form of Warrant (Filed With SEC on February 12, 2019)

Form of Pre-Funded Warrant (Filed With SEC on February 12, 2019)

GENOCEA BIOSCIENCES, INC. (25)